62gal said...
This is copy from google:
According to the Mayo Clinic, tamsulosin can affect the results of a prostate specific antigen (PSA) test, which is used to detect prostate cancer. Tamsulosin can also increase the risk of developing high-grade prostate cancer, so patients should inform their doctor if they are concerned about this risk.
If the information is from
this Mayo Cliic page, there may be some confusion. I believe the sentence there refers (only) to the dutasteride in Jalyn, which is the
combination of tamulosin and dutasteride.
Note: The black box FDA (and Mayo Clinic) warning about
5α-reductase Inhibitors like dutasteride and finasteride increasing the risk of high-grade PCa, as I understand it, is because the lower PSA that results can give a false sense of complacency, leading to a delayed diagnosis of PCa. This delay could give one's cancer time to progress to high-risk disease. (See the
Wiki article.)
In other words, these medications do not directly increase the risk of high-grade PCa. All uros know that after a few months on these drugs you have to double the results of your PSA tests to know your "effective" PSA.
Actually, there is evidence that 5α-reductase Inhibitors actually
lower the risk of
low-grade PCa by about
25%, although the FDA has not approved the use of that claim in drug advertising.
Tamulosin (Flomax) taken by itself has an entirely different mechanism of action for improving BPH symptoms, and AFAIK does not cause a lowering of one's PSA or the indirect risk of delayed cancer diagnosis.
Djin